Table 5.
Characteristics |
EACS GU regimens adjusted OR |
|
---|---|---|
(95% CI) | P | |
N. enrolled per center§ |
|
|
≥20 patients |
0.56 (0.23-1.37) |
0.2 |
Female gender |
1.92 (0.71-5.18) |
0.2 |
Immigrant status |
|
|
Foreign birth |
1.4 (0.71-2.74) |
0.33 |
Age at diagnosis |
|
|
10 years increase |
1.23 (1.02-1.48) |
0.03 |
Years since diagnosis* |
|
0.12 |
2-10 |
0.68 (0.24-1.9) |
|
<10 |
1.08 (0.39-3.04) |
|
Alcohol consumption |
|
|
Ever |
2.21 (0.84-5.86) |
0.11 |
Disease stage° |
|
|
Cirrhosis/HCC |
1.57 (0.75-3.29) |
0.23 |
HBeAg |
|
|
Positivity |
0.83 (0.44-1.55) |
0.56 |
HCV co-infection |
|
|
Yes |
2.74 (1.39-5.41) |
0.004 |
HDV co-infection |
|
|
Yes |
0.41 (0.18-0.93) |
0.03 |
Previous treatment |
|
|
Yes | 0.4 (0.19-0.83) | 0.01 |
Reference: § = ≤20 patients enrolled; * = <2 years;° = chronic hepatitis. EACS, European AIDS Clinical Society; OR, odds ratio; CI, confidence interval; HCC, hepatocellular carcinoma.